Live feed07:00:00·3dPRReleasevia QuantisnowLabcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening TestByQuantisnow·Wall Street's wire, on your screen.LH· Labcorp Holdings Inc.Health Care